Paclitaxel | Docetaxel | Irinotecan | 10-DAB III | Baccatin | Sequoyitol | (2R,3S)-3-Phenylisoserine Hydrochloride | (4S,5R)-3-(tetra-butoxycarbonyl)-2,2-dimethyl-4-phenyl-oxazolidine-5-carboxylic acid | (4S,5R)-3-(3-benzoyl)-2,2-dimethyl-4-phenyloxazolidine-5-carboxylic acid--Shanghai Jinhe Bio-Tech Co., Ltd.

logn

username:

paswword:

Welcome to visit us at our booth: A66 during CPHI Japan 2012.

We will participate in CPHI Japan 2012 which will be held in Tokyo, Japan during March 21-23, 2012 You are warmly invited to visit our booth.( Booth No. A66).

	Welcome to our company’s booth on API CHINA & INTERPHEX CHINA 2013, NO.: 3BE56
	Welcome to our company's booth on CPHI, ICSE & BioPh China 2013, NO.: W1B12
	Welcome to our company's booth on CPHI Worldwide 2013 (Frankfurt, Germany), NO.: 31E12
	Welcome to our company's booth on CPHI INDIA 2013, NO.: D16 in Hall 1
	The project of technical reform & innovation for our GMP plant ...
	The main building of our new GMP plant has been completed.
	Our company vigorously carries out the project of Shanghai...
	Our project was awarded the technological invention prize of Shanghai ...
	Our Project Docetaxel is ranked as Innovation fund for Technology Based Firms Projects.
	Jinhe, was granted as the honor of “2005-2006 year’s advanced private enterprise “
	Jinhe’s research and development center was set up in Shanghai Juke Bio-tech Park
	A new patent of Jinhe Bio-Tec called “a new method of Docetaxel synthesis” was published.

CopyRight(C)2006,Shanghai Jinhe Bio-Pharmaceutical Co.,Ltd. All Rights Reserved. Supported by NetSun ChinaChemNet ChemNet